Intellectual Property Magazine
A decade of difference
TaylorWessing’s Paul England looks at changes in IP and pharma over the past10 years
Paul England, Taylor Wessing
Just a decade ago, during the financial crisis, the lifesciences sector, dominated by small-molecule pharmaceuticals, was
beingsqueezed.